메뉴 건너뛰기




Volumn 101, Issue 8, 2012, Pages 2668-2674

Drug delivery trends in clinical trials and translational medicine: Growth in biologic molecule development and impact on rheumatoid arthritis, crohn's disease, and colitis

Author keywords

Biotechnology; Drug interaction; Formulation; Macromolecular drug delivery; Pharmacodynamics; Pharmacokinetics; Physicochemical properties; Prodrugs; Proteins; Targeted drug delivery

Indexed keywords

ADALIMUMAB; AIN 457; ANRUKINZUMAB; BEVACIZUMAB; BIOLOGICAL PRODUCT; BRODALUMAB; CCX282 B; CERTOLIZUMAB PEGOL; DRUG CARRIER; ETANERCEPT; GOLIMUMAB; INFLIXIMAB; INSULIN; INSULIN ASPART; INSULIN GLARGINE; INSULIN LISPRO; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; OZORALIZUMAB; PEGINTERFERON ALPHA2A; PF 00547659; PF 04236921; PRODRUG; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RITUXIMAB; TRASTUZUMAB; UNCLASSIFIED DRUG; UNINDEXED DRUG; USTEKINUMAB; VEDOLIZUMAB;

EID: 84862865685     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.23154     Document Type: Article
Times cited : (14)

References (14)
  • 1
    • 52449085743 scopus 로고    scopus 로고
    • Drug delivery trends in clinical trials and translational medicine
    • Chien JY, Ho RJ. 2008. Drug delivery trends in clinical trials and translational medicine. J Pharm Sci 97(7):2543-2547.
    • (2008) J Pharm Sci , vol.97 , Issue.7 , pp. 2543-2547
    • Chien, J.Y.1    Ho, R.J.2
  • 2
    • 85030486429 scopus 로고    scopus 로고
    • NIH. Accessed March 13, 2012, at: .
    • NIH. Accessed March 13, 2012, at:
  • 3
    • 67049114280 scopus 로고    scopus 로고
    • Drug delivery trends in clinical trials and translational medicine: Updated analysis of ClinicalTrials.gov database
    • Ho RJ, Chien JY. 2009. Drug delivery trends in clinical trials and translational medicine: Updated analysis of ClinicalTrials.gov database. J Pharm Sci 98(6):1928-1934.
    • (2009) J Pharm Sci , vol.98 , Issue.6 , pp. 1928-1934
    • Ho, R.J.1    Chien, J.Y.2
  • 4
    • 78650046009 scopus 로고    scopus 로고
    • Drug delivery trends in clinical trials and translational medicine: Evaluation of pharmacokinetic properties in special populations
    • Chien JY, Ho RJ. 2011. Drug delivery trends in clinical trials and translational medicine: Evaluation of pharmacokinetic properties in special populations. J Pharm Sci 100(1):53-58.
    • (2011) J Pharm Sci , vol.100 , Issue.1 , pp. 53-58
    • Chien, J.Y.1    Ho, R.J.2
  • 5
    • 78049512700 scopus 로고    scopus 로고
    • Prodrugs: Some thoughts and current issues
    • Stella VJ. 2010. Prodrugs: Some thoughts and current issues. J Pharm Sci 99(12):4755-4765.
    • (2010) J Pharm Sci , vol.99 , Issue.12 , pp. 4755-4765
    • Stella, V.J.1
  • 6
    • 80052273661 scopus 로고    scopus 로고
    • Lead PK commentary: Predicting human pharmacokinetics
    • Rowland M, Benet LZ. 2011. Lead PK commentary: Predicting human pharmacokinetics. J Pharm Sci 100(10):4047-4049.
    • (2011) J Pharm Sci , vol.100 , Issue.10 , pp. 4047-4049
    • Rowland, M.1    Benet, L.Z.2
  • 11
    • 39649084919 scopus 로고    scopus 로고
    • The FDA critical path initiative and its influence on new drug development
    • Woodcock J, Woosley R. 2008. The FDA critical path initiative and its influence on new drug development. Annu Rev Med 59:1-12.
    • (2008) Annu Rev Med , vol.59 , pp. 1-12
    • Woodcock, J.1    Woosley, R.2
  • 12
    • 67049103751 scopus 로고    scopus 로고
    • Not all protein drugs and vaccines of the same name are identical
    • Ho RJ, Gibaldi M, editors. Hoboken, NJ: John Wiley and Sons
    • Ho RJ, Gibaldi M. 2003. Not all protein drugs and vaccines of the same name are identical. In: Ho RJ, Gibaldi M, editors. Biotechnology and Biopharmaceuticals: Transforming Proteins and Genes into Drugs. Hoboken, NJ: John Wiley and Sons. pp. 2-9.
    • (2003) Biotechnology and Biopharmaceuticals: Transforming Proteins and Genes into Drugs , pp. 2-9
    • Ho, R.J.1    Gibaldi, M.2
  • 14
    • 84855833408 scopus 로고    scopus 로고
    • Systematic review and meta-analysis of the efficacy and safety of existing TNF blocking agents in treatment of rheumatoid arthritis
    • Aaltonen KJ, Virkki LM, Malmivaara A, Konttinen YT, Nordstrom DC, Blom M. 2012. Systematic review and meta-analysis of the efficacy and safety of existing TNF blocking agents in treatment of rheumatoid arthritis. PLoS One 7(1):e30275.
    • (2012) PLoS One , vol.7 , Issue.1
    • Aaltonen, K.J.1    Virkki, L.M.2    Malmivaara, A.3    Konttinen, Y.T.4    Nordstrom, D.C.5    Blom, M.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.